Fosun International Ltd stock (HK0656038673): Gains 1.44% to HK$4.23

Fosun International Ltd shares rose 1.44% on May 11, 2026, closing at HK$4.23 on the Hong Kong exchange amid positive technical signals.

Fosun International Ltd stock advanced 1.44% on Monday, May 11, 2026, climbing from HK$4.17 to HK$4.23 during the trading session on the Hong Kong Stock Exchange, StockInvest.us as of May 12, 2026. The stock showed intraday volatility with a 3.10% fluctuation range in recent sessions, reflecting medium risk levels supported by accumulated volume at HK$4.59.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Fosun International Limited
• Sector/industry: Conglomerate (healthcare, insurance, tourism)
• Headquarters/country: China
• Core markets: China, global
• Key revenue drivers: Healthcare, financial services
• Home exchange/listing venue: Hong Kong Stock Exchange (0656.HK)
• Trading currency: HKD

Fosun International Ltd: core business model

Fosun International Ltd operates as a diversified conglomerate with roots in China, focusing on healthcare, insurance, intelligent manufacturing, and tourism. Founded in 1992, the company has expanded globally through acquisitions and investments, emphasizing a 'consumer-driven' strategy targeting happiness ecosystems. Its model integrates industrial operations with financial services, serving over 600 million global customers.

Main revenue and product drivers for Fosun International Ltd

Healthcare remains a primary revenue driver, with subsidiaries like Shanghai Henlius Biotech contributing biologics and Fosun Pharma advancing pharmaceuticals. Financial services through Pramerica Fukoku provide insurance products, while tourism assets including Club Med resorts generate leisure income. In Q1 2025 data published alongside recent trading updates, these segments underpinned steady performance amid market volatility.

Conclusion

Fosun International Ltd's recent 1.44% price gain on May 11, 2026, highlights short-term positive momentum amid buy signals from moving averages. The conglomerate's diversified model spans key sectors with global reach, offering exposure relevant to US investors tracking China-linked healthcare and consumer plays. Market dynamics continue to influence performance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.